title: Erosive conjunctivitis and punctal stenosis secondary to docetaxel (taxotere).
abstract: OBJECTIVE
  To report a case of erosive conjunctivitis and punctal stenosis occurring secondarily in a patient who underwent administration of docetaxel.
  
  
  METHODS
  Observational case report: a 58-year-old female with metastatic breast cancer developed erosive conjunctivitis and punctal stenosis after undergoing administration of systemic docetaxel.
  
  
  RESULTS
  Resolution of the erosive conjunctivitis occurred after discontinuation of docetaxel. The punctal stenosis persisted.
  
  
  CONCLUSIONS
  Patients receiving treatment with docetaxel require frequent monitoring to discover potentially irreversible ocular damage.
authors.affiliation: Bascom Palmer Eye Institute, Miami, FL 33418, USA. cskolnick@med.miami.edu
authors.forename: Craig A
authors.initials: CA
authors.lastname: Skolnick
authors.forename: Donald J
authors.initials: DJ
authors.lastname: Doughman
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D003231:Conjunctivitis / Q000139:chemically induced*; D000077143:Docetaxel; D005260:Female; D006801:Humans; D007767:Lacrimal Duct Obstruction / Q000139:chemically induced*; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives*; D043823:Taxoids
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel